In the last trading session, 5.53 million Citius Pharmaceuticals Inc (NASDAQ:CTXR) shares changed hands as the company’s beta touched 1.05. With the company’s per share price at $1.53 changed hands at $0.2 or 15.04% during last session, the market valuation stood at $17.10M. CTXR’s last price was a discount, traded about -1615.69% off its 52-week high of $26.25. The share price had its 52-week low at $0.65, which suggests the last value was 57.52% up since then. When we look at Citius Pharmaceuticals Inc’s average trading volume, we note the 10-day average is 2.21 million shares, with the 3-month average coming to 2.32 million.
Analysts gave the Citius Pharmaceuticals Inc (CTXR) stock a consensus recommendation rating of Buy, calculated at a mean rating of 1.67. If we narrow down to specifics, the data shows that 0 out of 1 analysts rate the stock as a Sell, with a further 0 assigning it an Overweight rating. Of the remaining, 0 recommended CTXR as a Hold, 1 felt it is a Buy and 0 rated the stock as Underweight.
Citius Pharmaceuticals Inc (NASDAQ:CTXR) trade information
Instantly CTXR was in green as seen at the end of in last trading. With action 41.67%, the performance over the past five days has been green. The company’s shares are showing year-to-date downside of -90.87%, with the 5-day performance at 41.67% in the green. However, in the 30-day time frame, Citius Pharmaceuticals Inc (NASDAQ:CTXR) is 118.57% up. Looking at the short shares, we see there were 1.35 million shares sold at short interest cover period of 0.27 days.
Looking at the company’s year-on-year earnings, data shows that the past 5-year has an earnings growth rate of 20.90%. The 2025 estimates are for Citius Pharmaceuticals Inc earnings to increase by 66.50%.
CTXR Dividends
Citius Pharmaceuticals Inc is expected to release its next quarterly earnings report on 2025-May-14.
Citius Pharmaceuticals Inc (NASDAQ:CTXR)’s Major holders
If we look at who the major shareholders are, we find that insiders hold 4.41% of Citius Pharmaceuticals Inc shares while 5.74% of the shares are in the hands of institutional holders. The share float percentage for the stock currently stands at 6.01%. There are 5.74% institutions holding the Citius Pharmaceuticals Inc stock share, with ARMISTICE CAPITAL, LLC the top institutional holder. As of 2024-06-30, the company held 6.3845% of the shares, roughly 10.16 million CTXR shares worth $5.93 million.
VANGUARD GROUP INC holds the second largest percentage of outstanding shares, with 3.9776% or 6.33 million shares worth $3.69 million as of 2024-06-30.
